MedPharm’s Post

Leveraging costs is pivotal these days, especially for high-ticket items such as prescription medications. With @CMS claim audits projected to rise in the next few years, payers must ensure the organizations they partner with are prepared with essential documentation. We’ve identified five key actions payers can take to balance pharmaceutical costs. Find them here: https://bit.ly/3xonkRt. #healthcare #healthcaresolutions #healthinsurance

Exciting update! Starting in 2024, the annual ceiling for pharmaceutical prices for seniors is dropping to $2000. At DiRx, our mission is twofold: to educate individuals about the pharmaceutical landscape and to offer more accessible medication options for all Americans. Stay informed and empowered with DiRx! 💊🎉 #bigpharma #pharma #healthcare #healthinsurance #prescriptions #genericmedicine #americanhealthcare #dirx #dirxhealth

Behind every pill, there's a story of precision and care. Proudly partnering with pharmaceutical third-party manufacturers to bring quality healthcare solutions to life. 💊✨#pharmaquality #medicationmatters #ThirdPartyManufacturing #precisionmedicine #HealthcarePartnerships #PharmaTechnology #pharmaqualityassurance #manufacturingexcellence

In pharmacy benefit management, rebates are financial incentives provided by pharmaceutical manufacturers to PBMs like Intercept Rx. 💰 These rebates are negotiated based on the volume or value of medications purchased and are typically tied to the drug's inclusion in health plan formularies. At Intercept Rx, these rebates are channeled back to the companies we partner with, directly contributing to reducing out-of-pocket costs for consumers. This strategic approach helps make essential medications more affordable and supports better health outcomes. #PharmacyBenefits #HealthBenefitsCosts #InterceptRx #Rebates

Experience the magic of Mandevis Pharma as we shape PCD dreams into business realities. With our expertise and commitment, your pharmaceutical aspirations are within reach. Let's make your vision a successful reality together! 💼💊 #MandevisPharma #PCD #PharmaSuccess

"With over a decade of expertise, Celera Healthcare continues to push the boundaries of pharmaceutical innovation. Trust in our commitment to delivering breakthrough solutions for a healthier tomorrow. Experience the difference with Celera's cutting-edge products and unwavering dedication to quality. #CeleraHealthcare #PharmaceuticalInnovation #HealthcareExcellence #BreakthroughsInMedicine #TrustedQuality #HealthAndWellness #MedicalAdvancements #PharmaLeaders #InnovationInHealthcare #DecadeOfTrust #CeleraSolutions #HealthcareInnovation"

Looking forward to presenting my poster on "Clinical and Economic Impact of Patient Support Programs" at the Royal Pharmaceutical Society conference on 8th November. Co-authored with Ejike, this work highlights how patient support programs improve outcomes and reduce costs. Thanks to HealthNet Homecare (UK) Ltd for the support! #RPSConference #HealthcareInnovation #PatientSupport #PharmacyLeadership #MedicationAdherence #PAM

Employers, Great overview of the current state of the Big PBM Industry. Please educate yourselves as required by the CAA regulations and your Fiduciary responsibilities. This information will really make you reconsider your view of your PBM. If this enlightens you and you want to act, please contact me to discuss our Fiduciary Options that consistently results in Better Outcomes and Lower Cost! mmincy@us-rxcare.com #CEO #CFO #COO #CHRO #CAA #Fiduciary #DoTheRightThing

A great refresher and morning coffee read! ☕ Prescription drug contracting in the United States has evolved over decades from discounts provided to members of early health maintenance organization plans to rebate contracts to more complex value-based purchasing arrangements. This primer describes the history of contracting between pharmaceutical manufacturers and managed care pharmacy organizations and details the various contracting methods used today. #marketaccess #access #drugpricing #pricing #payer #drugcontracting #valuebasedcare #valuebasedpricing #reimbursement #valuestrategy #commercial #pbm #pharmacy #patientjourney #patientcentricity #patientoutcomes #launch #pharma #specialtypharmacy #amcp

FTC and HHS Seek Info on How Industry Middlemen Affect Generic Industry: FTC and HHS are jointly seeking more intel on how the practices of two types of pharmaceutical drug middlemen — group purchasing organizations (GPOs) and drug wholesalers — may be contributing to generic drug shortages. #fda #financial #lifesciences